Vascular permeability factor and lipase produced by Acinetobacter baumannii treated with imipenem

Biomedical Letters

Volumn 60, Issue 235, 1999, Pages 91-96

  Hostacka A ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

Acinetobacter baumannii; Imipenem; Lipase; Vascular permeability factor

Indexed keywords

EID: 0033246413     PISSN: 0961088X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. ADINOLFI L. E. and Bonventre P. F. 1988. Enhanced phagocytosis, killing and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem. Antimicrob. Agents Chemother. 32 1012-8.
2. AVRIL J. L. and Mesnard R. 1991. Factors influencing the virulence of Acinetobacter. In The Biology of Acinetobacter. pp 77-82. Edited by K. J. Towner, E. Bergogne-Bérézin and C. A. Fewson. Plenum Publishing Corp., New York.
3. BAUMANN P. 1968. Isolation of Acinetobacter from soil and water. J. Bact. 96 39-42.
4. BERGOGNE-BÉRÉZIN E. and Towner K. J. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9 148-65.
5. CAI S., Simionato M. R. L. Mayer M. P. A., Novo N. F. and Zelante F. 1994. Effects of subinhibitory concentrations of chemical agents on hydrophobicity and in vitro adherence of Streptococcus mutans and Streptococcus sanguis. Caries Res. 28 335-41.
6. DHARMSTHITI S., Pratuangdejkul J., Theeragool G. and Luchai S. 1998. Lipase activity and gene cloning of Acinetobacter calcoaceticus LP009. J. gen. appl. Microbiol. 44 139-45.
7. GETCHELL-WHITE S. I., Donowitz L. G. and Gröschel D. H. M. 1989. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus. Infect. Control Hosp. Epidemiol. 10 402-7.
8. GLATZ B. A., Spira W. M. and Goepfert J. M. 1974. Alteration of vascular permeability in rabbits by culture filtrates of Bacillus cereus and related species. Infect. Immun. 10 299-303.
9. GRIF K., Dierich M. P., Karch H. and Allenberger F. 1998. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O 157 following exposure to sub-inhibitory concentrations of antimicrobial agents. Eur. J. clin. Microbiol. Infect. Dis. 17 761-6.
10. GRIMWOOD K., To M., Rabin H. R. and Woods D. E. 1989. Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrob. Agents Chemother. 33 41-7.
11. HORREVORTS A., Bergman K., Kollee L., Breuker I., Tjernberg I. and Dijkshoorn L. 1995. Clinical and epidemiological investigations of Acinetobacter genospecies 3 in a neonatal intensive care unit. J. clin. Microbiol. 33 1567-72.
12. HOŠTACKÁ A. and Majtán V. 1993. Alterations in Pseudomonas aeruginosa exoproducts by sub-MICs of some antibiotics. Folia Microbiol. 38 349-52.
13. HOŠTACKÁ A. 1997. Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones. Microbios 91 137-43.
14. HOŠTACKÁ A. and Kováčikovà Z. 1999. Cytotoxic activity of Acinetobacter baumannii after treatment with aminoglycosides. Arzneim. Forsch. Drug Res. In press.
15. HOŠTACKÁ A. 1999. The effect of meropenem on the vascular permeability factor produced by Acinetobacter baumannii. Arzneim. Forsch. Drug Res. In press.
16. KÖLJALG S., Vuopio-Varkila J., Lyytikäinen O., Mikelsaar M. and Wadström T. 1996. Cell surface properties of Acinetobacter baumannii. APMIS 104 659-66.
17. MAJTÁN V. and Majtánová Ľ. 1998. In vitro activity of subinhibitory concentrations of quinolones on the surface hydrophobicity of Enterobacter cloacae. Microbios 95 117-23.
18. MAJTÁNOVÁ Ľ., Hoštacká A. and Majtán V. 1994. Effects of subinhibitory concentrations of antibiotics on biological properties of Salmonella typhimurium. Folia Microbiol. 39 141-6.
19. MOLINARI G., Guzmán C. A., Pesce A. and Schito G. C. 1993. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J. Antimicrob. Chemother. 31 681-8.
20. OBANA Y. 1986. Pathogenic significance of Acinetobacter calcoaceticus: analysis of experimental infection in mice. Microbiol. Immunol. 30 645-57.
21. PATON R. H., Miles R. S., Hood J. and Amyes S. G. B. 1993. ARI-I: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2 81-8.
22. POLLACK M. 1984. The virulence of Pseudomonas aeruginosa. Rev. Infect. Dis. 6 S617-26.
23. RICHARDS R. M. E., Eumkeb G. and Marshall D. 1997. Is the ultrastructural damage caused by subinhibitory concentrations of trimethoprim and sulphadiazine part of their normal mechanism of action? Microbios 92 183-97.
24. RUPP M. E. and Hamer K. E. 1998. Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis. J. Antimicrob. Chemother. 41 155-61.
25. SEIFERT H., Baginski R., Schultze A. and Pulverer G. 1993. Antimicrobial susceptibility of Acinetobacter species. Antimicrob. Agents Chemother. 37 750-3.
26. SMITH A. W., Freeman S., Minett W. G. and Lambert P. A. 1990. Characterization of a siderophore from Acinetobacter calcoaceticus. FEMS Microbiol. Letters 70 29-32.
27. STRAUS D. C., Lonon M. K. and Hutson J. C. 1992. Inhibition of rat alveolar macrophage phagocytic function by a Pseudomonas cepacia lipase. J. med. Microbiol. 37 335-40.
28. TATEDA K., Ishii Y., Hirakata Y., Matsumoto T., Ohno A. and Yamaguchi K. 1994. Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity. J. Antimicrob. Chemother. 34 931-42.
29. TAWFIK A. F., Ramadan M. A. and Shibl A. M. 1997. Inhibition of motility and adherence of Proteus mirabilis to uroepithelial cells by subinhibitory concentrations of amikacin. Chemotherapy 43 424-9.
30. VAHABOGLU H., Öztürk R., Aygün G., Coskunkan F., Yaman A., Kaygusuz A., Leblebiciouglu H., Balik I., Aydin K. and Otkun M. 1997. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob. Agents Chemother. 41 2265-9.
31. VILLERS D., Espaze E., Coste-Burel M., Giauffret F., Ninin E., Nicolas F. and Richet H. 1998. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann. intern. Med. 129 182-9.
32. WANG T. J. and Chen T. L. 1998. Lipase production by Acinetobacter radioresistens in a batch fill-and-draw culture. Appl. Biochem. Biotechnol. 73 185-94.
33. WILLIAMS P. 1987. Sub-MICs of cefuroxime and ciprofloxacin influence interaction of complement and immunoglobulins with Klebsiella pneumoniae. Antimicrob. Agents Chemother. 31 758-62.
34. WOOD C. A. and Reboli A. C. 1993. Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J. infect. Dis. 68 1602-3.
35. ZAK O. and Kradolfer F. 1979. Effects of subminimal inhibitory concentrations of antibiotics in experimental infections. Rev. Infect. Dis. 1 862-79.